Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Enavate Sciences Gp, Llc
Form 13F · Q2 2026

Enavate Sciences Gp, Llc

CIK 1953107Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$345M
Reported book value
7
Positions
7
Quarters on record
Top 50
Positions

Enavate Sciences Gp, Llc — holdings

Top 7 positions of 7, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1SION Sionna Therapeutics Inc2.5M+0.0%$109M31.6%
2ZBIO Zenas Biopharma Inc3.9M+0.0%$99M28.8%
3IMNM Immunome Inc3.6M+0.0%$77M22.2%
4BBOT Bridgebio Oncology Therapeut2.6M+0.0%$20M5.8%
5CMPX Compass Therapeutics Inc7.8M+0.0%$17M4.9%
6UPB Upstream Bio Inc2.5M+0.0%$17M4.9%
7CAMP Camp4 Therapeutics Corp1.4M−34.9%$6M1.8%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.